JXSB2101003 | PDR001注射用粉末 | spartalizumab | Other | Biological Products(1) | Supplementary Application | 2021-04-14 | | Novartis Pharma Stein AG;Novartis Pharma Schweiz AG | | | view |
JXSL2000094 | PDR001注射用浓溶液 | spartalizumab | Injection | Biological Products | Import Drug Application | 2020-07-03 | 诺华(中国)生物医学研究有限公司 | China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG | In Review | 2020-07-02 | view |
JXSL1900101 | PDR001注射用浓溶液 | spartalizumab | Injection | Biological Products | Import Drug Application | 2019-09-29 | 诺华(中国)生物医学研究有限公司 | China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG | In Review | 2019-09-28 | view |
JXSL1900102 | PDR001注射用粉末 | spartalizumab | Other | Biological Products | Import Drug Application | 2019-09-29 | 诺华(中国)生物医学研究有限公司 | China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG | In Review | 2019-09-28 | view |
JXSL1900021 | PDR001注射用浓溶液 | spartalizumab | Injection | Biological Products | Import Drug Application | 2019-02-25 | 诺华(中国)生物医学研究有限公司 | China Novartis Institutes For Biomedical Research Co Ltd;Novartis Pharma Schweiz AG | In Review | 2019-02-23 | view |
JXSL1700041 | PDR001 | spartalizumab | Other | Biological Products | Import Drug Application | 2017-08-16 | Novartis Pharma AG | Novartis Pharma Schweiz AG | Certificate Issued | 2017-12-20 | view |
JXSL1600032 | PDR001 | spartalizumab | Other | Biological Products | Import Drug Application | 2016-07-04 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd;Novartis Pharma Schweiz AG | Certificate Issued | 2017-05-18 | view |
JXSL1600016 | PDR001 | spartalizumab | Other | Biological Products | Import Drug Application | 2016-03-23 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd;Novartis Pharma Schweiz AG | Certificate Issued | 2017-05-26 | view |